<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="56411">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02371759</url>
  </required_header>
  <id_info>
    <org_study_id>UBelgrade 534/2</org_study_id>
    <secondary_id>175021</secondary_id>
    <nct_id>NCT02371759</nct_id>
  </id_info>
  <brief_title>Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2</brief_title>
  <acronym>LCIOADMT2</acronym>
  <official_title>Efficacy and Safety of Intraoral Local Anesthesia by Lidocaine + Clonidine in Patients With Diabetes Mellitus Type 2</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Belgrade</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Belgrade</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether 2% lidocaine (L) + clonidine (C) (15
      mcg/ml) as a vasoconstrictor achieves efficient (equal or better parameters of intraoral
      local anesthesia in comparison to 2% lidocaine + epinephrine (E) (1:80 000)) and safe
      (stable cardiovascular parameters - systolic, diastolic, mean blood pressure and heart rate)
      intraoral local anesthesia in patients with Diabetes mellitus type 2.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with diabetes mellitus type 2, represent a risk for performing regional anesthesia
      techniques due to microvascular (microangiopathy, neuropathy) and macrovascular
      (hypertension, coronary heart disease) complications. There is evidence that local
      anesthetic toxicity may be increased in diabetic setting due to underlying neuropathy; while
      interaction of diabetic blood vessels with vasoconstrictors may be of importance because of
      microangiopathic changes. Lately, regional anesthesia protocol in general surgery for
      patients with diabetes mellitus was released, proposing reduction of local anesthetic
      concentration and avoiding epinephrine as vasoconstrictor.

      Oral cavity tissues in diabetes mellitus also suffer from neuropathy (burning, paresthesia,
      teeth loss, temporomandibular dysfunction, xerostomia) and microangiopathy (periodontal
      disease, salivary gland dysfunction). Most widely used vasoconstrictor for intraoral local
      anesthesia, epinephrine, is an alpha- and beta- adrenergic agonist. Because of its
      beta-adrenergic effects, epinephrine could adversely affect cardiovascular function,
      especially in risk patients. There are data suggesting that intraoral local anesthesia
      obtained with 2% lidocaine with clonidine, selective alpha 2-adrenoceptor agonist as a
      vasoconstrictor, is characterized with significantly more stable cardiovascular parameters
      and similar parameters of local anesthesia with respect to lidocaine with epinephrine in
      healthy and hypertensive patients.

      With regard to aforementioned, the aim of this randomized double-blind controlled clinical
      trial is to evaluate and compare efficacy and safety of intraoral local anesthesia obtained
      with 2% lidocaine (L) + clonidine (15 mcg/ml) (C) or 2% L + epinephrine (1:80 000) (E),
      comparing healthy and diabetes mellitus type 2 patients. Prior to tooth extraction, random
      allocation to one of four groups (L+C maxillary infiltration, L+C mandibular block, L+E
      maxillary infiltration and L+E mandibular block) is performed for diabetic (30 per group)
      and healthy (30 per group) patients. Parameters of local anesthesia (onset, duration,
      intensity, width of anesthetic field for maxillary infiltration), cardiovascular parameters
      (systolic, diastolic, mean arterial pressure; heart rate and electrocardiographic changes),
      quality of postoperative analgesia (assessed by Visual Analogue Scale, Numerical Rating
      Scale and number of consumed analgesics) and postoperative complications (infection,
      bleeding, paresthesia, delayed wound healing) are evaluated and compared.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of intraoral local anesthesia</measure>
    <time_frame>Up to 6 hours after local anesthesia injection</time_frame>
    <description>Time until cessation in soft tissue numbness</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Intensity of intraoral local anesthesia</measure>
    <time_frame>Up to 10 minutes after local anesthesia injection</time_frame>
    <description>Pain assessment by Visual Analogue Scale (VAS) and Numerical Rating Scale (NRS) during tooth extraction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in systolic blood pressure at 5 minutes</measure>
    <time_frame>baseline, 5 minutes</time_frame>
    <description>Clinically significant changes in systolic blood pressure at the time of local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in systolic blood pressure at 10 minutes</measure>
    <time_frame>baseline, 10 minutes</time_frame>
    <description>Clinically significant changes in systolic blood pressure 5 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in systolic blood pressure at 15 minutes</measure>
    <time_frame>baseline, 15 minutes</time_frame>
    <description>Clinically significant changes in systolic blood pressure 10 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in systolic blood pressure at 20 minutes</measure>
    <time_frame>baseline, 20 minutes</time_frame>
    <description>Clinically significant changes in systolic blood pressure 15 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in systolic blood pressure at 35 minutes</measure>
    <time_frame>baseline, 35 minutes</time_frame>
    <description>Clinically significant changes in systolic blood pressure 30 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in diastolic blood pressure at 5 minutes</measure>
    <time_frame>baseline, 5 minutes</time_frame>
    <description>Clinically significant changes in diastolic blood pressure at the time of local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in diastolic blood pressure at 10 minutes</measure>
    <time_frame>baseline, 10 minutes</time_frame>
    <description>Clinically significant changes in diastolic blood pressure 5 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in diastolic blood pressure at 15 minutes</measure>
    <time_frame>baseline,15 minutes</time_frame>
    <description>Clinically significant changes in diastolic blood pressure 10 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in diastolic blood pressure at 20 minutes</measure>
    <time_frame>baseline, 20 minutes</time_frame>
    <description>Clinically significant changes in diastolic blood pressure 15 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in diastolic blood pressure at 35 minutes</measure>
    <time_frame>baseline, 35 minutes</time_frame>
    <description>Clinically significant changes in diastolic blood pressure 30 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in heart rate at 5 minutes</measure>
    <time_frame>baseline, 5 minutes</time_frame>
    <description>Clinically significant changes in heart rate at the time of local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in heart rate at 10 minutes</measure>
    <time_frame>baseline, 10 minutes</time_frame>
    <description>Clinically significant changes in heart rate 5 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in heart rate at 15 minutes</measure>
    <time_frame>baseline, 15 minutes</time_frame>
    <description>Clinically significant changes in heart rate 10 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in heart rate at 20 minutes</measure>
    <time_frame>baseline, 20 minutes</time_frame>
    <description>Clinically significant changes in heart rate 15 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in heart rate at 35 minutes</measure>
    <time_frame>baseline, 35 minutes</time_frame>
    <description>Clinically significant changes in heart rate 30 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in electrocardiogram at 5 minutes</measure>
    <time_frame>baseline, 5 minutes</time_frame>
    <description>Clinically significant changes in ECG at the time of local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in electrocardiogram at 10 minutes</measure>
    <time_frame>baseline, 10 minutes</time_frame>
    <description>Clinically significant changes in ECG 5 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in electrocardiogram at 15 minutes</measure>
    <time_frame>baseline, 15 minutes</time_frame>
    <description>Clinically significant changes in ECG 10 minutes after local anesthesia injection</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change from baseline in electrocardiogram at 20 minutes</measure>
    <time_frame>baseline, 20 minutes</time_frame>
    <description>Clinically significant changes in ECG 15 minutes after local anesthesia injection</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Onset of intraoral local anesthesia</measure>
    <time_frame>Up to 10 minutes, until subjective feeling of soft tissue numbnes</time_frame>
    <description>Evaluated by pin-prick after subjective feeling of soft tissue numbness appeared after local anesthesia injection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Width of anesthetic field</measure>
    <time_frame>Up to 10 minutes after injection of local anesthesia</time_frame>
    <description>Soft tissue numbness area determined by pin-prick</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative analgesia</measure>
    <time_frame>up to 24 hours after tooth extraction</time_frame>
    <description>Number of analgesic doses required for postoperative pain control, VAS, NRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local postoperative complications</measure>
    <time_frame>24 hours, 7 days</time_frame>
    <description>Postoperative infection, postoperative bleeding, alveolitis, paresthesia, delayed wound healing by clinical examination</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">256</enrollment>
  <condition>Diabetes Mellitus</condition>
  <condition>Local Anesthesia</condition>
  <arm_group>
    <arm_group_label>Diabetics: L+C maxillary anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for maxillary infiltration anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics: L+C mandibular anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for mandibular block anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics: L+E maxillary anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%)+ epinephrine (1:80.000) for maxillary infiltration anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics: L+E mandibular anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%) + epinephrine (1:80.000) for mandibular block anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy: L+C maxillary anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for maxillary infiltration anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy: L+C mandibular anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%) + clonidine (15 mcg/ml) for mandibular block anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy: L+E maxillary anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%)+ epinephrine (1:80.000) for maxillary infiltration anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy: L+E mandibular anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single dose intraoral local anesthesia with 2ml lidocaine (2%) + epinephrine (1:80.000) for mandibular block anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>L+C maxillary anesthesia</intervention_name>
    <description>Maxillary anesthesia obtained by 2% lidocaine + clonidine (15 mcg/ml)</description>
    <arm_group_label>Diabetics: L+C maxillary anesthesia</arm_group_label>
    <arm_group_label>Healthy: L+C maxillary anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>L+C mandibular anesthesia</intervention_name>
    <description>Mandibular anesthesia obtained by 2% lidocaine + clonidine (15 mcg/ml)</description>
    <arm_group_label>Diabetics: L+C mandibular anesthesia</arm_group_label>
    <arm_group_label>Healthy: L+C mandibular anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>L+E maxillary anesthesia</intervention_name>
    <description>Maxillary anesthesia obtained by 2% lidocaine + epinephrine (1:80 000)</description>
    <arm_group_label>Diabetics: L+E maxillary anesthesia</arm_group_label>
    <arm_group_label>Healthy: L+E maxillary anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>L+E mandibular anesthesia</intervention_name>
    <description>Mandibular anesthesia obtained by 2% lidocaine + epinephrine (1:80 000)</description>
    <arm_group_label>Diabetics: L+E mandibular anesthesia</arm_group_label>
    <arm_group_label>Healthy: L+E mandibular anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy participants: ASA I

          -  Diabetic type 2 participants: ASA III (HbA1c level &lt; 9%)

          -  Required a single-root teeth indicated for non-complicated extraction

          -  Dental diagnosis of periodontal disease, tooth fracture, chronic periapical lesion
             and root infection

          -  Subjects give informed written consent

        Exclusion Criteria:

          -  Pregnancy and lactation

          -  Allergy to used drugs and food

          -  Hepatic and/or renal failure

          -  ASA IV patients

          -  Tobacco smokers

          -  History of alcoholism and/or drug abuse and addiction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dragica DM Stojic, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Dental Medicine, University of Belgrade</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bozidar M Brkovic, DDS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Dental Medicine, University of Belgrade</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marija S Milic, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>School of Dental Medicine, University of Belgrade</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>School of Dental Medicine, University of Belgrade</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 13, 2016</lastchanged_date>
  <firstreceived_date>February 4, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Belgrade</investigator_affiliation>
    <investigator_full_name>Bozidar Brkovic, DDS, MSc, PhD, Professor</investigator_full_name>
    <investigator_title>Professor, DDS, MSc, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Clonidine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
